Trials / Completed
CompletedNCT02579746
Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- University of Toronto · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The study examined the feasibility of the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC) intervention and its potential effects on blood pressure, health-related quality of life, and health service utilization. Half of participants received usual care while the other half received the DASHNa-CC intervention.
Detailed description
Hypertension has been identified as the most important risk factor for cardiovascular diseases and accounts for a large proportion of stroke, myocardial infarction and heart failure in the Chinese population. While unhealthy diet has been identified as a modifiable risk factor for hypertension, there is a lack of culturally sensitive dietary intervention targeting Chinese Canadians. The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DASHNa-CC | The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up. |
| BEHAVIORAL | usual care | education booklet, encouragement of physician visit, use of public health resources if needed |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-12-01
- Completion
- 2015-08-01
- First posted
- 2015-10-20
- Last updated
- 2015-10-20
Source: ClinicalTrials.gov record NCT02579746. Inclusion in this directory is not an endorsement.